Santé log2h
Cannabix Technologies to Attend Tennessee Safety and Health Conference to Exhibit Alcohol and Marijuana Breath Testing Technologies
Cannabix and AlcoPro Inc. will attend TSHC in Nashville, TN. AlcoPro (of Knoxville, TN) is collaborating with Cannabix to ...
Santé log2h
Aspargo Labs Expands Global Leadership Team
Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting ...
Santé log2h
Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization
Conduit expands its partnership with Sarborg to apply advanced machine learning-driven analysis on clinical data from its AstraZeneca-acquired assets, aiming to uncover new insights and optimize ...
Santé log2h
Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025
As previously announced, Dr. Rieger will participate in a fireside chat at the 24 th Annual Needham Virtual Healthcare Conference. Participants may access a live webcast of the event by clicking the ...
Santé log2h
ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug Conjugate
ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created from ALX Oncology’s proprietary linker-payload platform ...
Santé log2h
Opus Genetics Files Definitive Proxy Statement and Sends Letter to Stockholders Highlighting the Company’s Transformation and Progress
This year’s Annual Meeting of Stockholders (the “Annual Meeting”) of Opus Genetics, Inc. (“Opus” or the “Company”) is scheduled to be held on April 30, 2025. This meeting is a particularly important ...
Santé log2h
Noom appoints Dr. Jeffrey Egler as Chief Medical Officer to Lead Innovation in Healthy Aging and Longevity
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, announced today that Dr.
Santé log2h
Stryker to announce financial results for its first quarter of fiscal year 2025
Stryker will host a webcast at 4:30 p.m. ET on Thursday, May 1, 2025, to discuss its first quarter 2025 results. The webcast can be accessed at Stryker - Events & Presentations . An archive of the ...
Santé log2h
Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States
EPYSQLI® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and generalized ...
Santé log2h
Adagene to Present at Stifel’s 2025 Virtual Targeted Oncology Forum
About Adagene Adagene Inc. (Nasdaq: ADAG) is a platform-driven, clinical-stage biotechnology company committed to transforming the discovery and development of novel antibody-based cancer ...
Santé log2h
Treace Announces Upcoming Board Chair Transition
Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot ...
Santé log2h
Solid Biosciences to Participate at Upcoming Investor Conferences
CHARLESTOWN, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for ...